<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876185</url>
  </required_header>
  <id_info>
    <org_study_id>ICU_2015_39</org_study_id>
    <nct_id>NCT02876185</nct_id>
  </id_info>
  <brief_title>Evaluation of the Possibility to Delegate Glaucoma Surveillance to Orthoptists in Hospital</brief_title>
  <acronym>GLAUS</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <brief_summary>
    <textblock>
      Glaucoma is a progressive optical neuropathy, generally associated with ocular hypertension.
      The treatment aims to stabilize the visual field deficiencies by lowering the intraocular
      pressure. Due to the fluctuation of the visual field test and re-test measures, the European
      recommendations are to obtain 6 visual field tests in 2 years (or one every 4 months) in
      order to know if the pathology is progressing despite the current treatment (or if the
      treatment is necessary, in cases of intraocular hypertensions). The lack of ophthalmologists
      renders the monitoring of a beginning glaucoma, rarely compatible with the present
      recommendations. It is therefore crucial to evaluate new therapeutic alternatives, when faced
      to a decreasing medical demography and an increase the patient's needs.

      This study should allow to validate the possibility to delegate monitoring tasks to
      orthoptists during glaucoma surveillance. To organize the delegation of this surveillance to
      orthoptists would permit a better distribution of the ophthalmologist's activities.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2016</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>detection by the orthoptists of an abnormality that would require an anticipated ophthalmologic consultation</measure>
    <time_frame>20 month of follow-up</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Patients with glaucoma</arm_group_label>
    <description>Patients presenting an open-angle glaucoma or ocular hypertension</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Monitoring by an orthoptist then by an ophthalmologist</intervention_name>
    <description>At each visit, the usual monitoring tests will be collected and viewed by the orthoptist then by the ophthalmologist concerning the necessity of an anticipated ophthalmological consultation</description>
    <arm_group_label>Patients with glaucoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with an open-angle glaucoma or ocular hypertension
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age from 18 years old or more

          -  Open-angle glaucoma or ocular hypertension

        Exclusion Criteria:

          -  Other active ocular pathology

          -  Monophthalmic patients

          -  Patients requiring a Goldmann visual field exam

          -  Patients presenting with a superior and/or inferior deficit in the 10 central degrees
             of vision with at least 1 point, out of the 4 most central points of the visual field
             24-2, who has a p inferior to 1%

          -  Opposition of the patient to participate to the trial

          -  Pregnant women or breastfeeding

          -  Patient under juridical protection

          -  Lack of affiliation to social security or universal health coverage
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurence Salomon, MD</last_name>
    <phone>+33 1 48 03 64 31</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre hospitalier</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Milea, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Ambroise-Paré</name>
      <address>
        <city>Boulogne Billancourt</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Labbé, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Universitaire d'Ophtalmologie</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florent Aptel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondation Ophtalmologique A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Salomon, M.D.</last_name>
      <phone>0033148036431</phone>
      <email>lsalomon@for.paris</email>
    </contact>
    <investigator>
      <last_name>Cochereau Isabelle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lamirel Cédric, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2016</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma surveillance</keyword>
  <keyword>Orthoptist</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

